Filing Details
- Accession Number:
- 0001225208-15-022613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-17 17:27:14
- Reporting Period:
- 2015-12-15
- Filing Date:
- 2015-12-17
- Accepted Time:
- 2015-12-17 17:27:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204663 | H John Weiland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | President And Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-15 | 13,590 | $84.58 | 87,095 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-15 | 700 | $188.88 | 86,395 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-15 | 3,551 | $187.12 | 82,844 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-15 | 9,339 | $187.79 | 73,505 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-16 | 1,668 | $190.30 | 71,837 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-16 | 1,687 | $191.61 | 70,150 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-16 | 2,741 | $189.50 | 67,409 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2015-12-15 | 13,590 | $0.00 | 13,590 | $84.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,831 | Indirect | 401(k) Plan |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $188.60 to $189.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $186.51 to $187.495. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $187.51 to $188.43. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $189.86 to $190.85. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $191.02 to $191.91. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $188.86 to $189.85. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Option fully vested on December 14, 2015.
Billionaire Hedge Funds
